Acetaminophen/Propoxyphene Napsylate

对乙酰氨基酚/萘磺酸丙氧芬

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcetaminophen/Propoxyphene Napsylate
Drug Alias Name萘磺酸丙氧芬/对乙酰氨基酚Propoxyphene Napsylate and AcetaminophenAcetaminophen and Propoxyphene NapsylatePropoxyphene Napsylate/AcetaminophenDarvocet-N 100 +[6] 
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsCyclooxygenases inhibitorsKappa opioid receptor antagonists +[4] 
TargetsMu opioid receptorKappa opioid receptorδ-opioid receptor +[4] 
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1972/12/19
Country/TerritoryUnited States
CombinationsYes AcetaminophenPropoxyphene Napsylate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesXanodyne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXanodyne Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN02BE51
Related LinksN/A